IFNG and melanoma: In melanoma cell lines, disruptive mutations of JAK1 or JAK2 (downstream elements of IFN signaling) have been shown to abrogate PD-L1 expression upon exposure to IFN-γ, suggesting a mechanism for innate resistance to PD-1 blockade66.